Upvote
Downvote
Associate Director, Translational Toxicology, Preclinical Development
Share Job
- Suggest Revision
Full-time
- We aspire to develop medicines across multiple therapeutic modalities, including RNA editing, splicing and silencing, using our proprietary discovery and drug development platform that combines best-in-class nucleic acid chemistry with the ability to target disease biology in new ways.
- In 2023 we are executing against multiple milestones, including advancing our differentiated exon skipping portfolio in Duchenne muscular dystrophy, bringing the first-ever investigational RNA editing therapeutic into clinical development, and announcing our next slate of pipeline programs.
- The candidate should possess an in-depth understanding of safety pharmacology, investigative and regulatory toxicology, and have experience designing and critically evaluating results of exploratory and GLP-compliant toxicology studies.
- DVM/PhD or PhD in biology, toxicology or related field, Board certification in toxicology is highly desirable
- Represent PCDS at team meetings and coordinate between PCDS and other functions including CMC, Regulatory Affairs, Clinical Operations, and Platform and Discovery Sciences
Active Job
Updated 13 days agoSimilar Job
Relevance
Active